Benefit Corporation: a path to affordable gene therapies?
Crossref DOI link: https://doi.org/10.1038/s41591-019-0676-z
Published Online: 2019-11-25
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fischer, Alain
Dewatripont, Mathias
Goldman, Michel
Text and Data Mining valid from 2019-11-25
Version of Record valid from 2019-11-25
Article History
First Online: 25 November 2019
Competing interests
: The authors declare no competing interests.